Upstate Active Clinical Trials
Study Title:Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled
adaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke
What is the purpose of the study?The MOST study is designed to find out whether adding one of two blood-thinning medicines (argatroban or eptifibatide) to standard treatment helps to decrease the impact of strokes and is safe. Earlier studies have shown that it seems safe and may be helpful to add argatroban or eptifibatide to tPA (standard treatment) to help dissolve clots causing stroke.
Upstate Institutional Review Board (IRB) Number:1344888
Patient Age Group:Adults
Principal Investigator:Julius Gene S Latorre
Who can I contact for more information?
Name: Lena F Deb